A potential interpretation is that colorectal cancers with suboptimal APC inactivation progress via alternative pathways, for example, increased KRAS signaling, in line with recent work suggesting pathway reciprocity between APC–MYC and KRAS pathways (31). The gene discussed is APC; the disease is colorectal cancer.